CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating activities:
Net loss	$ (95,140)	$ (15,696)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	26,292	15,033
Unrealized loss on foreign currency	4,906	1,127
Stock based compensation	18,859	850
Change in fair value of warrants	(2,964)
Change in fair value of derivative liability	(3,525)
Amortization of debt discount and deferred issuance costs	3,863
Deferred income tax	1,957	(4,336)
Loss on disposition of subsidiary		612
(Gain) loss on disposition of assets	(500)	220
Provision for doubtful accounts	654	(687)
Unrealized gain on investment	(1,260)
Non-cash lease expense	14,962
Impairment expense	2,160
Changes in operating assets and liabilities:
Accounts receivable	50,761	32,245
Prepaid expenses and other current assets and prepaid expenses and other assets	(6,469)	(17,070)
Accounts payable	4,133	1,779
Deferred rent		(2,004)
Accrued compensation	(9,048)	1,494
Accrued expenses, other current liabilities and other liabilities	(3,177)	(1,818)
Lease liabilities	(17,728)
Deferred revenue	3,367	(851)
Cash (used in) provided by operating activities	(7,897)	10,898
Investing activities:
Capital expenditures	(4,528)	(1,789)
Capitalization of internal-use software	(9,746)	(7,587)
Proceeds from sale of asset	500
Cash from acquired business, net		5,200
Cash of disposed subsidiary, less proceeds on disposition		(724)
Cash used in investing activities	(13,774)	(4,900)
Financing activities:
Proceeds from issuance of common stock		35,000
Proceeds from exercise of stock options	360	581
Payment for shares withheld for employee taxes	(1,670)
Borrowings (payments) on revolving credit facilities	5,000	(1,304)
Deferred reverse recapitalization costs	(585)
Cash provided by financing activities	3,105	34,277
Effect of currency translation on cash and cash equivalents	(2,031)	(804)
Net (decrease) increase in cash, cash equivalents and restricted cash	(20,597)	39,471
Cash and cash equivalents and restricted cash at beginning of period	79,733	106,126
Cash and cash equivalents and restricted cash at end of period	$ 59,136	$ 145,597